Bausch Health Companies (BHC) Inventory Average (2010 - 2026)
Bausch Health Companies (BHC) reported Inventory Average of $1.6 billion for Q1 2026, up 0.69% on a YoY basis from $1.6 billion in Q1 2025, and little changed sequentially from $1.6 billion in Q4 2025.
Bausch Health Companies (BHC) Inventory Average (2010 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 17 years of Inventory Average data on file, last reported at $1.6 billion in Q1 2026.
- For the quarter ending Q1 2026, Inventory Average rose 0.69% year-over-year to $1.6 billion; the trailing twelve-month figure through Mar 2026 stood at $1.6 billion (up 0.69% YoY), and the FY2025 full-year result was $1.6 billion, up 2.71% from the prior year.
- Inventory Average steadied at $1.6 billion in Q1 2026, from $1.6 billion in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $1.6 billion in Q2 2025 to a low of $1.0 billion in Q1 2022.
- A 5-year average of $1.4 billion and a median of $1.6 billion in 2024 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average slipped 6.08% in 2022 and soared 37.54% in 2024, its largest moves.
- Tracing BHC's Inventory Average over 5 years: stood at $1.1 billion in 2022, then jumped by 31.22% to $1.4 billion in 2023, then climbed by 15.41% to $1.6 billion in 2024, then dropped by 0.71% to $1.6 billion in 2025, then advanced by 0.09% to $1.6 billion in 2026.
- Business Quant data shows BHC's Inventory Average at $1.6 billion in Q1 2026, $1.6 billion in Q4 2025, and $1.6 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 9.02 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 180.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.11 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.96 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 66.75 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.73 Bn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | 1.62 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.62 Bn |
| Dec 31, 2025 | 1.61 Bn |
| Sep 30, 2025 | 1.63 Bn |
| Jun 30, 2025 | 1.63 Bn |
| Mar 31, 2025 | 1.60 Bn |
| Dec 31, 2024 | 1.63 Bn |
| Sep 30, 2024 | 1.63 Bn |
| Jun 30, 2024 | 1.62 Bn |
| Mar 31, 2024 | 1.59 Bn |
| Dec 31, 2023 | 1.41 Bn |
| Sep 30, 2023 | 1.26 Bn |
| Jun 30, 2023 | 1.23 Bn |
| Mar 31, 2023 | 1.16 Bn |
| Dec 31, 2022 | 1.07 Bn |
| Sep 30, 2022 | 1.06 Bn |
| Jun 30, 2022 | 1.06 Bn |
| Mar 31, 2022 | 1.02 Bn |
| Dec 31, 2021 | 1.03 Bn |
| Sep 30, 2021 | 1.07 Bn |
| Jun 30, 2021 | 1.08 Bn |